Proc Amer Assoc Cancer Res, Volume 47, 2006
5524
Globally, DNA in all eukaryotic cells is underwound ( i.e. , negatively supercoiled). This puts energy into the genetic material and makes it easier to separate the two strands of the double helix. Because of the universal nature of underwound DNA, negatively supercoiled substrates have been used for many previous studies on the actions of anticancer drugs against topoisomerases. Other studies have utilized linear nucleic acid substrates, especially for mapping sites of drug-induced DNA scission. In contrast to global underwinding, the movement of DNA tracking systems through the genetic material results in an acute overwinding ( i.e. , positive supercoiling) immediately ahead of replication or transcription enzymes. Collisions with DNA tracking systems are critical for the conversion of transient topoisomerase-DNA cleavage complexes to permanent strand breaks. Since DNA is overwound immediately ahead of these systems, cleavage complexes most likely to produce permanent strand breaks should be formed between topoisomerases and positively supercoiled molecules. Despite the importance of DNA tracking enzymes to drug efficacy, relationships between the geometry of DNA supercoils and the activity of topoisomerase-targeted anticancer agents have not been characterized. Therefore, the ability of human topoisomerase IIα and β, and topoisomerase I to cleave positively supercoiled DNA was assessed in the absence and presence of anticancer drugs. Topoisomerase IIα and β maintained ∼4-fold lower levels of cleavage complexes with positively supercoiled DNA than with negatively supercoiled molecules. Topoisomerase IIα also displayed lower cleavage with overwound substrates in the presence of non-intercalative drugs. Decreased drug efficacy was due primarily to a drop in baseline ( i.e. , non-drug) cleavage, rather than an altered interaction with the enzyme-DNA complex. In addition, the geometry of DNA supercoils did not affect the site specificity of DNA scission. Similar results were seen for topoisomerase IIβ, but the effects of DNA geometry on drug-induced scission were less pronounced. With both topoisomerase IIα and β, intercalative drugs displayed higher relative cleavage enhancement with positively supercoiled DNA. This appeared to result primarily from negative effects of intercalative agents on underwound substrates. In contrast to the type II enzymes, topoisomerase I maintained ∼3-fold higher levels of cleavage complexes with positively supercoiled substrates and displayed an even more dramatic increase in the presence of camptothecin. These findings suggest that the geometry of DNA supercoils has a profound influence on topoisomerase-mediated DNA scission, and that topoisomerase I may be an intrinsically more lethal target for anticancer drugs than either topoisomerase IIα or β. This work was supported by NIH Grants GM33944 and T32 CA09582.